Industry
Children's Hospitals Face 16 Active Pediatric Drug Shortages Including Six IV Products
Pediatric drugs represent the therapeutic category most affected by active drug shortages, with 16 ongoing shortages including six involving IV fluids and additives. Children's hospitals face unique challenges managing these shortages compared to adult health systems due to weight-based dosing, limited alternative formulations, and smaller patient volumes that reduce purchasing leverage. The article examines operational strategies pediatric hospitals use to manage supply disruptions, though specific policy interventions or effective dates are not detailed.
Why it mattersMedicaid managed care organizations with pediatric or CHIP populations must address formulary disruptions, prior authorization protocols, and care continuity when contracted children's hospitals face drug shortages affecting covered services.